NEW YORK (GenomeWeb News) – Sequencing technology developer Stratos Genomics said today that it raised $2 million in Series A-5 financing in the fall of 2013.

The company said that the funding was contingent on the demonstration of sequence read lengths of 210 bases for its Sequencing by Expansion, or SBX, technology. The SBX approach converts DNA into a surrogate molecule called an Xpandomer that is read via a nanopore detector.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.